Active

DRAGONPHARMA

Switched

BE0847159297

Rechtspersoon Private limited company 1 establishment

Rue Jean Jean 3, 7340 Colfontaine

Active for

14 year, 2 months

Financials

Financial year 2025

Worth noting

  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ 29,249

▲ 26% vs 2024

Profit

Caution

€ -8,675

▲ 34% vs 2024

Debts

Low

€ 374,160

▼ 5% vs 2024

DRAGONPHARMA from Colfontaine, company number BE0847159297, closed financial year 2025 with a result of € -8,675 after tax. For that financial year DRAGONPHARMA recorded a gross margin of € 29,249 and equity of € 355,790. Compared with financial year 2024, the result moved from € -13,096 to € -8,675. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What happened at DRAGONPHARMA?

What happened at DRAGONPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: loss of € 8,675. Source: NBB ↗
  • Start of the company according to the CBE. KBO
  • New establishment in Colfontaine. KBO

In short

From € 656 profit in 2021 to € 8,675 loss in 2025.

Paid € 2 in corporate taxes since 2021.

Best year ever: 2021, with € 656 profit.

A new publication or filing at DRAGONPHARMA? We notify you, reason included.

Follow DRAGONPHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Pascal Conem
DRAGONPHARMA

Behind DRAGONPHARMA is Pascal Conem. Pascal Conem is also behind CONEMPHAR.

See the full network in the app

Directors

According to the 2025 annual accounts

Pascal Conem

Director

Also active at: CONEMPHAR

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Jean Jean 3

7340 Colfontaine

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0847.159.297
VAT number
BE 0847.159.297
Registered office
Rue Jean Jean 3, 7340 Colfontaine
Names & denominations
DRAGONPHARMA
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
5 July 2012
Peppol
Active · Active since 16 Dec 2025

Frequently asked questions

What is the enterprise number of DRAGONPHARMA?
The enterprise number of DRAGONPHARMA is BE0847159297.
What is the address of DRAGONPHARMA?
The registered office of DRAGONPHARMA is located at Rue Jean Jean 3, 7340 Colfontaine.
When was DRAGONPHARMA founded?
DRAGONPHARMA was founded on 5 July 2012.
Does DRAGONPHARMA have a website?
No website is currently known for DRAGONPHARMA.
How much profit did DRAGONPHARMA make in 2025?
DRAGONPHARMA recorded a loss after taxes of € 8,675 in financial year 2025.
What is the revenue of DRAGONPHARMA?
As a small company, DRAGONPHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 29,249.
Where can I find the annual accounts of DRAGONPHARMA?
DRAGONPHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of DRAGONPHARMA?
According to the 2025 annual accounts, the directors of DRAGONPHARMA are: Pascal Conem.
Who owns DRAGONPHARMA?
Behind DRAGONPHARMA is Pascal Conem. Pascal Conem is also behind CONEMPHAR.